Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
Titel:
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
Auteur:
Ugurel, S. Schadendorf, D. Horny, K. Sucker, A. Schramm, S. Utikal, J. Pföhler, C. Herbst, R. Schilling, B. Blank, C. Becker, J.C. Paschen, A. Zimmer, L. Livingstone, E. Horn, P.A. Rebmann, V.